Business Description
Acadia Healthcare Co Inc
NAICS : 622110
SIC : 8062
ISIN : US00404A1097
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 7.93 | |||||
Interest Coverage | 6.25 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.2 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.9 | |||||
3-Year EBITDA Growth Rate | -25 | |||||
3-Year EPS without NRI Growth Rate | 16.9 | |||||
3-Year FCF Growth Rate | -55.9 | |||||
3-Year Book Growth Rate | 12.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.13 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.75 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.15 | |||||
9-Day RSI | 54.18 | |||||
14-Day RSI | 46.43 | |||||
6-1 Month Momentum % | 7.17 | |||||
12-1 Month Momentum % | 3.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.67 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 18.31 | |||||
Days Sales Outstanding | 43.34 | |||||
Days Payable | 472.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | 1.24 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 96.38 | |||||
Operating Margin % | 17.52 | |||||
Net Margin % | -0.74 | |||||
FCF Margin % | 1.3 | |||||
ROE % | -0.77 | |||||
ROA % | -0.42 | |||||
ROIC % | 6.77 | |||||
ROC (Joel Greenblatt) % | 2.53 | |||||
ROCE % | 1.24 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 20.47 | |||||
PE Ratio without NRI | 20.94 | |||||
Shiller PE Ratio | 306.63 | |||||
PS Ratio | 2.25 | |||||
PB Ratio | 2.41 | |||||
Price-to-Tangible-Book | 13.91 | |||||
Price-to-Free-Cash-Flow | 173.69 | |||||
Price-to-Operating-Cash-Flow | 14.33 | |||||
EV-to-EBIT | 144.14 | |||||
EV-to-Forward-EBIT | 13.7 | |||||
EV-to-EBITDA | 43.27 | |||||
EV-to-Forward-EBITDA | 10.87 | |||||
EV-to-Revenue | 2.79 | |||||
EV-to-Forward-Revenue | 2.54 | |||||
EV-to-FCF | 214.15 | |||||
Price-to-Projected-FCF | 1.79 | |||||
Price-to-Median-PS-Value | 0.99 | |||||
Price-to-Graham-Number | 3.6 | |||||
Earnings Yield (Greenblatt) % | 0.69 | |||||
FCF Yield % | 0.56 | |||||
Forward Rate of Return (Yacktman) % | 6.41 |